EASTMAN CHEMICAL CO financials

  1. Home
  2. Financials
  3. EMN
EMN CIK 0000915389

Source: EDGAR filings · Built 2026-06-02T02:54:52Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 424.00M 688.00M 546.00M 364.00M 1.06B 1.07B
Working Capital 993.00M 1.39B 905.00M 527.00M 1.68B 1.50B
Net Debt 4.22B 4.18B 4.30B 4.66B 4.70B 5.05B
Gross Margin 21.07% 24.41% 22.38% 20.20% 23.86% 23.31%
Net Margin 5.42% 9.65% 9.71% 7.50% 8.18% 5.64%
Return on Equity (ROE) 7.95% 15.66% 16.38% 15.39% 15.02% 7.94%
Return on Assets (ROA) 3.19% 5.95% 6.11% 5.41% 5.52% 2.97%
Current Ratio 1.37× 1.51× 1.35× 1.16× 1.56× 1.74×
Debt-to-Equity 0.80× 0.87× 0.89× 1.00× 0.90× 0.93×
Effective Tax Rate 16.37% 15.77% 17.57% 18.53% 19.87% 7.74%
Cash Conversion Ratio 2.05× 1.42× 1.54× 1.23× 1.89× 3.04×
Accruals Ratio -0.03× -0.03× -0.03× -0.01× -0.05× -0.06×
SBC % of Revenue 0.55% 0.67% 0.69% 0.65% 0.67% 0.52%
CapEx Coverage 1.78× 2.15× 1.66× 1.60× 2.92× 3.80×
Free Cash Flow Per Share $3.67 $5.84 $4.57 $2.91 $7.76 $7.85

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 15.57× 11.91× 11.99× 12.83× 19.35× 28.65×
P/FCF 17.40× 15.65× 19.64× 27.95× 15.58× 12.77×
FCF Yield 5.75% 6.39% 5.09% 3.58% 6.42% 7.83%
P/S 1.63× 2.18× 2.17× 1.71× 2.56× 2.61×
P/B 2.40× 3.53× 3.67× 3.51× 4.70× 3.67×

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenues 8.75B 9.38B 9.21B 10.58B 10.48B 8.47B
Cost of Goods and Services Sold 6.91B 7.09B 7.15B 8.44B 7.98B 6.50B
Gross Profit 1.84B 2.29B 2.06B 2.14B 2.50B 1.98B
Research and Development Expense 255.00M 250.00M 239.00M 264.00M 254.00M 226.00M
Selling, General and Administrative Expense 658.00M 736.00M 727.00M 726.00M 795.00M 654.00M
Income Tax Expense (Benefit) 93.00M 170.00M 191.00M 181.00M 215.00M 41.00M
Net Income (Loss) Attributable to Parent 474.00M 905.00M 894.00M 793.00M 857.00M 478.00M
Earnings Per Share, Basic $4.14 $7.75 $7.54 $6.42 $6.35 $3.53
Weighted Average Number of Shares Outstanding, Basic 114.70M 116.70M 118.60M 123.50M 134.90M 135.50M
Earnings Per Share, Diluted $4.10 $7.67 $7.49 $6.35 $6.25 $3.50
Weighted Average Number of Shares Outstanding, Diluted 115.60M 117.90M 119.40M 124.90M 137.10M 136.50M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 566.00M 837.00M 548.00M 493.00M 459.00M 564.00M
Assets, Current 3.65B 4.10B 3.48B 3.78B 4.65B 3.54B
Assets 14.86B 15.21B 14.63B 14.67B 15.52B 16.08B
Liabilities, Current 2.65B 2.71B 2.58B 3.25B 2.97B 2.04B
Long-term Debt, Excluding Current Maturities 4.20B 4.57B 4.30B 4.03B 4.41B 5.27B
Liabilities 8.82B 9.36B 9.10B 9.43B 9.73B 9.97B
Stockholders' Equity Attributable to Parent 5.96B 5.78B 5.46B 5.15B 5.70B 6.02B
Common Stock, Shares, Outstanding 223.94M 223.59M 222.76M 222.35M 221.81M 220.64M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 970.00M 1.29B 1.37B 975.00M 1.62B 1.46B
Payments to Acquire Property, Plant, and Equipment 546.00M 599.00M 828.00M 611.00M 555.00M 383.00M
Net Cash Provided by (Used in) Investing Activities -462.00M -534.00M -432.00M 392.00M -29.00M -394.00M
Payments for Repurchase of Common Stock — — — — 900.00M —
Payments of Dividends 381.00M 379.00M 376.00M 381.00M 375.00M 358.00M
Net Cash Provided by (Used in) Financing Activities -797.00M -454.00M -888.00M -1.32B -1.69B -704.00M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (EMN CIK 0000915389), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

STRW

Strawberry Fields REIT, Inc.

CGEM

CULLINAN THERAPEUTICS, INC.

LENZ

LENZ THERAPEUTICS, INC.